Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1993 1
1998 1
2000 1
2002 1
2003 1
2004 1
2005 2
2006 6
2007 3
2008 6
2009 6
2010 6
2011 11
2012 16
2013 10
2014 7
2015 8
2016 21
2017 30
2018 31
2019 39
2020 42
Text availability
Article attribute
Article type
Publication date

Search Results

221 results
Results by year
Filters applied: . Clear all
Page 1
Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series.
Elms L, Shannon S, Hughes S, Lewis N. Elms L, et al. J Altern Complement Med. 2019 Apr;25(4):392-397. doi: 10.1089/acm.2018.0437. Epub 2018 Dec 13. J Altern Complement Med. 2019. PMID: 30543451 Free PMC article.
OBJECTIVES: Cannabidiol (CBD) is a non-psychotomimetic cannabinoid compound that is found in plants of the genus Cannabis. Preclinical research has suggested that CBD may have a beneficial effect in rodent models of post-traumatic stress disorder (PTSD). ...
OBJECTIVES: Cannabidiol (CBD) is a non-psychotomimetic cannabinoid compound that is found in plants of the genus Cannabis. Preclinica …
Cannabidiol, neuroprotection and neuropsychiatric disorders.
Campos AC, Fogaça MV, Sonego AB, Guimarães FS. Campos AC, et al. Pharmacol Res. 2016 Oct;112:119-127. doi: 10.1016/j.phrs.2016.01.033. Epub 2016 Feb 1. Pharmacol Res. 2016. PMID: 26845349 Review.
Cannabidiol (CBD) is a non-psychotomimetic phytocannabinoid derived from Cannabis sativa. It has possible therapeutic effects over a broad range of neuropsychiatric disorders. ...
Cannabidiol (CBD) is a non-psychotomimetic phytocannabinoid derived from Cannabis sativa. It has possible therapeutic effects over a …
Cannabidiol as a Potential Treatment for Anxiety Disorders.
Blessing EM, Steenkamp MM, Manzanares J, Marmar CR. Blessing EM, et al. Neurotherapeutics. 2015 Oct;12(4):825-36. doi: 10.1007/s13311-015-0387-1. Neurotherapeutics. 2015. PMID: 26341731 Free PMC article. Review.
Cannabidiol (CBD), a Cannabis sativa constituent, is a pharmacologically broad-spectrum drug that in recent years has drawn increasing interest as a treatment for a range of neuropsychiatric disorders. ...We found that existing preclinical evidence strongly supports CBD as …
Cannabidiol (CBD), a Cannabis sativa constituent, is a pharmacologically broad-spectrum drug that in recent years has drawn increasin …
Effectiveness of Cannabidiol Oil for Pediatric Anxiety and Insomnia as Part of Posttraumatic Stress Disorder: A Case Report.
Shannon S, Opila-Lehman J. Shannon S, et al. Perm J. 2016 Fall;20(4):16-005. doi: 10.7812/TPP/16-005. Epub 2016 Oct 12. Perm J. 2016. PMID: 27768570 Free PMC article.
INTRODUCTION: Anxiety and sleep disorders are often the result of posttraumatic stress disorder and can contribute to an impaired ability to focus and to demonstration of oppositional behaviors. ...This case study provides clinical data that support the use of cannabidi …
INTRODUCTION: Anxiety and sleep disorders are often the result of posttraumatic stress disorder and can contribute to an impaired abi …
Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age.
Crippa JA, Guimarães FS, Campos AC, Zuardi AW. Crippa JA, et al. Front Immunol. 2018 Sep 21;9:2009. doi: 10.3389/fimmu.2018.02009. eCollection 2018. Front Immunol. 2018. PMID: 30298064 Free PMC article. Review.
Background: Among the many cannabinoids in the cannabis plant, cannabidiol (CBD) is a compound that does not produce the typical subjective effects of marijuana. Objectives: The aim of the present review is to describe the main advances in the development of the experiment …
Background: Among the many cannabinoids in the cannabis plant, cannabidiol (CBD) is a compound that does not produce the typical subj …
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress.
Booz GW. Booz GW. Free Radic Biol Med. 2011 Sep 1;51(5):1054-61. doi: 10.1016/j.freeradbiomed.2011.01.007. Epub 2011 Jan 14. Free Radic Biol Med. 2011. PMID: 21238581 Free PMC article. Review.
If excessive or unresolved, however, immune-related oxidative stress can initiate further increasing levels of oxidative stress that cause organ damage and dysfunction. ...This review discusses recent studies suggesting that cannabidiol may have utility in tr …
If excessive or unresolved, however, immune-related oxidative stress can initiate further increasing levels of oxidative stress …
Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders.
Lee JLC, Bertoglio LJ, Guimarães FS, Stevenson CW. Lee JLC, et al. Br J Pharmacol. 2017 Oct;174(19):3242-3256. doi: 10.1111/bph.13724. Epub 2017 Mar 9. Br J Pharmacol. 2017. PMID: 28268256 Free PMC article. Review.
There is also accumulating evidence from animal studies investigating the effects of cannabidiol on fear memory processing indicating that it reduces learned fear in paradigms that are translationally relevant to phobias and post-traumatic stress disorder. ...The fi …
There is also accumulating evidence from animal studies investigating the effects of cannabidiol on fear memory processing indicating …
Antioxidative and Anti-Inflammatory Properties of Cannabidiol.
Atalay S, Jarocka-Karpowicz I, Skrzydlewska E. Atalay S, et al. Antioxidants (Basel). 2019 Dec 25;9(1):21. doi: 10.3390/antiox9010021. Antioxidants (Basel). 2019. PMID: 31881765 Free PMC article. Review.
Cannabidiol (CBD) is one of the main pharmacologically active phytocannabinoids of Cannabis sativa L. CBD is non-psychoactive but exerts a number of beneficial pharmacological effects, including anti-inflammatory and antioxidant properties. ...In addition, preclinical and …
Cannabidiol (CBD) is one of the main pharmacologically active phytocannabinoids of Cannabis sativa L. CBD is non-psychoactive but exe …
Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease.
Vallée A, Lecarpentier Y, Guillevin R, Vallée JN. Vallée A, et al. Acta Biochim Biophys Sin (Shanghai). 2017 Oct 1;49(10):853-866. doi: 10.1093/abbs/gmx073. Acta Biochim Biophys Sin (Shanghai). 2017. PMID: 28981597
AD shows oxidative stress and chronic inflammation. In AD, canonical Wingless-Int (Wnt)/β-catenin pathway is downregulated, whereas peroxisome proliferator-activated receptor γ (PPARγ) is increased. ...Cannabidiol (CBD) is a non-psychotomimetic phytocannabinoid from …
AD shows oxidative stress and chronic inflammation. In AD, canonical Wingless-Int (Wnt)/β-catenin pathway is downregulated, whereas p …
Cannabidiol as a Therapeutic Alternative for Post-traumatic Stress Disorder: From Bench Research to Confirmation in Human Trials.
Bitencourt RM, Takahashi RN. Bitencourt RM, et al. Front Neurosci. 2018 Jul 24;12:502. doi: 10.3389/fnins.2018.00502. eCollection 2018. Front Neurosci. 2018. PMID: 30087591 Free PMC article. Review.
Post-traumatic stress disorder (PTSD) is characterized by poor adaptation to a traumatic experience. This disorder affects approximately 10% of people at some point in life. ...Cannabidiol (CBD), a phytocannabinoid constituent of Cannabis sativa without the psychoac …
Post-traumatic stress disorder (PTSD) is characterized by poor adaptation to a traumatic experience. This disorder affects approximat …
221 results
Jump to page
Feedback